Bright.md Named Vendor to Watch by Chilmark Research

PORTLAND, Ore., Nov. 19, 2019 /PRNewswire/ — In its new report “Primary Care for the 21st Century: Technology-enabled and On Demand,” Chilmark Research lauds Bright.md’s ability to make positive impacts on access, burden, and costs—for both providers and patients.

“The U.S. primary care system no longer meets the needs of its patients or providers,” the report notes. “New technological approaches combined with the drive to move care to lower cost settings are creating care models that better meet patient needs and are accessible on demand.”

Chilmark researcher Alex Lennox-Miller identifies “three types of solutions that can contribute to or complement the modern technology-enabled primary care practice, promising to meet the challenges of increased demand, changing needs, and evolving payments.” These solutions include Telemedicine; Virtual and Remote Care Platforms; and AI-enabled Assistants, Symptom Checkers, and Chatbots.

Placing Bright.md in the third category, the report identified three product differentiators: true machine learning (ML) for conducting evaluations and constructing notes; asynchronous diagnosis with direct provider review; and billing, treatment, prescription, and next steps as needed and on demand.

With SmartExam, “provider workflow involves only direct clinical evaluation and judgment, significantly reducing active provider time. This addresses one of the biggest weaknesses of the telehealth field, as appointments are still heavily time restricted and a number of information and survey questions are still necessary.”

“Once again, Chilmark has proven its researchers have their fingers on the pulse of what is driving change in health care,” said Dr. Ray Costantini, Bright.md CEO and co-founder. “The Bright.md team and I are honored to be recognized. And we’re beyond excited that the potential of care automation is evident to a well-respected analyst who knows his way around health care.”

About Bright.md
Founded in 2014 and based in Portland, Oregon, Bright.md is a leading healthcare automation company dedicated to modernizing direct-to-patient telehealth for healthcare systems with its AI-powered virtual-care platform, SmartExam. Bright.md partners with premier healthcare organizations in North America, including three of the top five not-for-profit health systems in the United States. These partners offer SmartExam to more than 10 million patients who are seeking convenient urgent and primary care online. Bright.md has been named the Leader in the “Forrester New Wave™: Virtual Care Solutions for Digital Health” report, a Gartner Cool Vendor in Healthcare, a Vendor to Watch by Chilmark Research, and is the preferred choice of AVIA’s Virtual Access cohort. Bright.md is venture-backed by B Capital Group, Seven Peaks Ventures, Pritzker Group Venture Capital, Oregon Venture Fund and the Stanford-StartX Fund. For more information, visit Bright.md or go to go.bright.com/chilmark to read an excerpt of what Chilmark has to say about Bright.md’s impact on the future of primary care.

 

View original content:http://www.prnewswire.com/news-releases/brightmd-named-vendor-to-watch-by-chilmark-research-300960694.html

SOURCE Bright.md

Staff

Recent Posts

Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by…

21 minutes ago

AssureCare Announces Parth Shah’s Promotion to Senior Vice President of Customer Success and Enterprise AI Delivery

CINCINNATI, Feb. 3, 2026 /PRNewswire/ -- AssureCare® LLC, a leading healthcare technology company delivering an…

21 minutes ago

Doxim Scales Utility Payments Team to Support Rapid Market Growth

Doxim's Utility Payments Team will drive seamless, omnichannel billing-to-payments solutions for utilities to bridge the…

21 minutes ago

Amplifire Recognized by Brandon Hall Group for Breakthrough AI Authoring Technology

BOULDER, Colo., Feb. 3, 2026 /PRNewswire/ -- Amplifire, the leading adaptive learning platform built on patented…

21 minutes ago

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates…

21 minutes ago